R.PR
REGISTERED-PRINCIPAL REGISTER
11/30/2021
Back to search
Official data from USPTO
CUREMARK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CUREMARK
ST13
US500000090322325Class
5, 42, 44
Filing
90322325
Registration
6573013
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
10/17/2022
Trademark type
Word
Nice classes
5, 42, 44
Filing date
11/16/2020
Registration date
11/30/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/30/2021
Last transaction
10/17/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
01/01/2004
First use in commerce
01/01/2004
Drawing code
4
Owner type
16
Owner location
Rye Brook, NY
Examiner
KUMIS,SCOTT N
Law office
N90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Curemark, LLC
Representatives
Nicole K. McLaughlin DUANE MORRIS LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the diagnosistreatment and prevention of viralbacterialfungalparasitic metabolicendocrinehepatologicalrespiratorynervous systemneurologicalgastrointestinaldigestiveinflammatorypulmonaryhormonaldermatologicalpsychiatricaddictivebehavioralinfectiousaddictivemusculoskeletalcardiovascularophthalmiccardiopulmonarygenitourinarysexual dysfunctiononcological and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of InfluenzaCoronavirusespancreatic deficienciesgastrointestinal diseaseinternal malabsorption syndromesAutismAutism Spectrum DisorderAttention Deficit Hyperactivity Disorder and Williams Syndrome; Antibacterialantiviral and antifungal preparations for skin and wound healing; disinfectants and antiseptics; antimicrobial cleansers for sanitation purposes; Medical assays for testing of bodily fluids and tissues for testing of enzymes in humans; biological preparations for medical testing; diagnostic preparations for medical purposes; testing kits comprised of medical diagnostic reagents and assays for testing enzymes and body fluids for use in disease detection; medical diagnostic reagents and assays for testing of enzymes and body fluids; chemical preparations for medical testing; diagnostic biomarker reagents for medical testing; all the foregoing for the diagnosis and treatment of viralbacterialfungalparasitic metabolicendocrinehepatologicalrespiratorynervous systemneurologicalgastrointestinaldigestiveinflammatorypulmonaryhormonaldermatologicalpsychiatricaddictivebehavioralinfectiousaddictivemusculoskeletalcardiovascularophthalmiccardiopulmonarygenitourinarysexual dysfunctiononcological and immune system related diseases and disorders
Class 42
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical research; Development of pharmaceuticals and medical devices for others; Providing temporary use of non-downloadable computer software that allows users to make determinations regarding neurological diseasesspecifically baseline stagingdata gathering and monitoring of earlymiddle and late stage neurological diseases; Design and development of medical assays for others; clinical research and development of treatments for viralbacterialfungalparasitic metabolicendocrinehepatologicalrespiratorynervous systemneurologicalgastrointestinaldigestiveinflammatorypulmonaryhormonaldermatologicalpsychiatricaddictivebehavioralinfectiousaddictivemusculoskeletalcardiovascularophthalmiccardiopulmonarygenitourinarysexual dysfunctiononcological and immune system related diseases and disorders; clinical research and development of treatments for the treatment and prevention of InfluenzaCoronavirusespancreatic deficienciesgastrointestinal diseaseinternal malabsorption syndromesAutismAutism Spectrum DisorderAttention Deficit Hyperactivity Disorder and Williams Syndrome; clinical research and development of treatments for antibacterialantiviralantifungal preparations for skin and wound healing; clinical research and development of disinfectantsantiseptics and antimicrobial cleansers for sanitation purposes; medical and scientific research services in the field of digestion and detection of enzymes or biological substances in the body
Class 44
Medical testing for diagnostic and treatment purposes; Medical consultations; medical testing for diagnostic treatment purposes in the fields of viralbacterialfungalparasitic metabolicendocrinehepatologicalrespiratorynervous systemneurologicalgastrointestinaldigestiveinflammatorypulmonaryhormonaldermatologicalpsychiatricaddictivebehavioralinfectiousaddictivemusculoskeletalcardiovascularophthalmiccardiopulmonarygenitourinarysexual dysfunctiononcological and immune system related diseases and disorders; medical testing for diagnostic treatment and prevention of InfluenzaCoronavirusespancreatic deficienciesgastrointestinal diseaseinternal malabsorption syndromesAutismAutism Spectrum DisorderAttention Deficit Hyperactivity Disorder and Williams Syndrome; Medical diagnostic testingmonitoring and reporting services; performing diagnosis of diseases; Health care servicesthe administration of medical assays for the detection of enzymes in humans
Publications
History of USPTO decisions and trademark events.
21 publications found
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/14/2021
PUBO
PUBLISHED FOR OPPOSITION
09/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/26/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/06/2021
DOCK
ASSIGNED TO EXAMINER
07/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/09/2021
ALIE
ASSIGNED TO LIE
07/01/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/03/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/03/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/03/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/03/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/03/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/29/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/26/2021
GNSL
LETTER OF SUSPENSION E-MAILED
04/26/2021
CNSL
SUSPENSION LETTER WRITTEN
04/26/2021
DOCK
ASSIGNED TO EXAMINER
04/26/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/15/2021
NWAP
NEW APPLICATION ENTERED
11/19/2020
Continuous trademark protection
Get notified about every new filing that threatens CUREMARK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.